Skip to main content

Table 2 List of tau antibodies used in this study

From: A post-translational modification signature defines changes in soluble tau correlating with oligomerization in early stage Alzheimer’s disease brain

NameSpeciesCompanyCat No.
Tau12mouseBiolegendSIG-39416
Tau5mouseAbcamab80579
Tau1mouseMilliporeMAB3420
DakorabbitAgilent DakoA0024
BT2mouseThermo FisherMN1010
HT7mouseThermo FisherMN1000
T22rabbitSigma-AldrichABN454-I
nY18mouseBiolegend829,701
nY29mouseMilliporeMAB2244
acK280rabbitAnaspecAS-56077
meK311mouseBiolegendMMS-5102
C3-D421mouseMillipore36–017
pY18mouseNovusbioNBP2–42402
pT181rabbitThermo Fisher701,530
pS198rabbitAbcamab79540
pS199rabbitThermo Fisher701,054
pS202rabbitAnaspecAS-28017
pS199/202rabbitThermo Fisher44-768G
pT205rabbitAbcamab181206
pT212rabbitAbcamab51053
pS214rabbitThermo FisherPA5–35762
pT217rabbitThermo Fisher44–744
pT231rabbitThermo Fisher701,056
pS235rabbitThermo FisherPIPA535761
pS238mouseAbcamab128889
pS356rabbitAbcamab51036
pS396rabbitThermo Fisher44-752G
pS400rabbitAnaspecAS-54978
pS404rabbitThermo Fisher44-758G
pS409rabbitAbcamab4861
pS416rabbitAbcamab119391
pS422rabbitAbcamab79415